Uranium Royalty Corp. (UROY)
Valuation Overview•Is Uranium Royalty Corp. Overvalued or Undervalued?
Trading at a relative discount to industry peers, suggesting a specific risk premium is applied.
Fragile underlying quality score of 44/100; weak margins or elevated debt leverage warrant caution.
Wall Street forecasts a balanced outlook with consensus price targets near the current price.
Verdict: Average quality business weighed down by significant profitability concerns.
Wall Street sentiment is generally neutral. The company currently dilutes shareholders to fund operations and growth rather than returning capital.
UROY struggles with subpar profitability and pressured margins. This is backed by a fortress balance sheet, holding significant net cash ($13M) and minimal debt risk.
The company maintains stable top-line performance paired with stable bottom-line earnings. However, profitability remains a major concern with severely compressed operating margins (3.3%).
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $16.7M | -63.5% | — | — | — | |
| EBITDA | $3.0M | — | +5.1% | — | — | |
| Net Income | $2.0M | -157.8% | -9.9% | — | — | |
| EPS (Diluted) | $0.01 | -152.6% | — | — | — | |
| Free Cash Flow | $8.8M | +79.5% | +36.3% | -26.3% | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 17.7% | 15.6% | 15.6% | 15.6% |
| Operating Margin | 3.3% | -13.8% | -13.8% | -13.8% |
| Net Margin | 8.0% | -18.5% | -18.5% | -18.5% |
| FCF Margin | 74.3% | -163.7% | -163.7% | -163.7% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q1'26Latest | $-0.01 | $0.01 | +200.0% | ||
| Q4'25 | $-0.01 | $0.01 | +252.2% | ||
| Q3'25 | $-0.01 | $0.01 | +200.0% | ||
| Q3'25 | $-0.01 | $-0.01 | +0.0% | ||
| Q1'25 | $-0.01 | $-0.01 | +0.0% | ||
| Q4'24 | $0.01 | $-0.00 | -125.2% | ||
| Q3'24 | — | $-0.01 | — | ||
| Q3'24 | — | $0.01 | — |
Total return is +17.1% (1Y), lagging the benchmark by -7.9%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | -24.0% | -33.3% | — |
| 1Y | +17.1% | -7.9% | — |
| 3YCAGR | +11.8% | -7.1% | — |
| 5YCAGR | +4.1% | -7.9% | — |
| 10YCAGR | +12.3% | -1.1% | — |
The S&P 500 is at 31.3x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about Uranium Royalty Corp. (UROY) valuation, health, and returns.
Based on peer relative multiples, Uranium Royalty Corp. appears Cheap versus peers compared to industry peers.
Uranium Royalty Corp. has multiple valuation anchors: Peer Relative Fair Value: $4.30. A convergence of these signals offers higher conviction.
Uranium Royalty Corp. displays fair financial health with a composite quality score of 44/100, supported by a Altman Z-Score of 100.0 (safe zone), Piotroski F-Score of 1/9, Return on Invested Capital (ROIC) of -1.3%.
Uranium Royalty Corp. does not return material capital to shareholders via dividends or share repurchases, electing to retain earnings to fund internal growth.
Uranium Royalty Corp.'s current growth trajectory is Stable. The company achieved -63.5% 1Y revenue growth and -152.6% 1Y EPS growth, compared to its 3Y revenue CAGR of N/A.
Wall Street consensus is Buy based on 1 analysts, beating EPS expectations in 50% of recent quarters with a 3-quarter streak. The consensus price target represents a N/A change from current levels.
Investment risks for Uranium Royalty Corp. include: -48.9% 1-year max drawdown, high beta (2.66x market volatility). Volatility risk is characterized by a beta of 2.66x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.